James C. D'Arecca serves as the Executive Vice President and Chief Financial Officer at Haemonetics Corporation, a global healthcare company dedicated to providing innovative solutions for blood and plasma supply management. In his role, D'Arecca is responsible for overseeing the company's financial operations, strategic planning, and investor relations. His leadership has been instrumental in guiding Haemonetics through a period of significant growth and transformation, ensuring the company's financial stability and success. Before joining Haemonetics, D'Arecca held several high-level financial positions at various organizations, showcasing his extensive experience in the healthcare and financial sectors. He previously served as the Chief Financial Officer at Becton Dickinson's Medical Segment, where he played a key role in driving the company's financial performance and strategic initiatives. D'Arecca's career also includes a notable tenure at Baxter International, where he held multiple finance leadership roles, further solidifying his expertise in the industry. D'Arecca's achievements extend beyond his corporate roles, as he is recognized for his strategic vision and ability to navigate complex financial landscapes. Under his guidance, Haemonetics has successfully implemented cost-saving measures and expanded its global presence, strengthening its position in the competitive healthcare market. His commitment to fostering a culture of innovation and efficiency has been a driving force behind the company's continued success, making him a respected leader in the field.